[1]支晓娟.粤港澳大湾区中药专利分析与思考[J].中国中医药图书情报杂志,2021,45(6):18-22.[doi:10.3969/j.issn.2095-5707.2021.06.004]
 ZHI Xiao-juan.Analysis and Thinking on Patent of Chinese Materia Medica in Guangdong-Hong Kong-Macao Greater Bay Area[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(6):18-22.[doi:10.3969/j.issn.2095-5707.2021.06.004]
点击复制

粤港澳大湾区中药专利分析与思考

参考文献/References:

[1] 黄蓓.2019年政府工作报告提出支持中医药事业传承创新发展[J].中医药管理杂志,2019,27(5):2.
[2] 国家中医药管理局.《粤港澳大湾区中医药高地建设方案(2020—2025年)》发布:加快形成中医药高地建设新格局[EB/OL].(2020-10-23)[2021-04-19].http://www.satcm.gov.cn/hudongjiaoliu/guanfangweixin/2020-10-23/17715.html.
[3] 肖国华,王春,姜禾,等.专利分析评价指标体系的设计与构建[J].图书情报工作,2008,52(3):96-99.
[4] 甄思圆,李海燕.中成药高价值专利评价指标体系的构建研究[J].中国药房,2020,31(17):2152-2157.
[5] 黄庆,曹津燕,瞿卫军,等.专利评价指标体系(一)——专利评价指标体系的设计和构建[J].知识产权,2004,14(5):25-28.
[6] 陈创荣,冯毅翀,陈旭红,等.抗肿瘤中药专利申请分析及其建议[J].中医肿瘤学杂志,2021,3(1):21-24,12.

相似文献/References:

[1]李哲,常暖*,李黎.中药院内制剂政策历史、现状及对策[J].中国中医药图书情报杂志,2014,38(1):38.[doi:10.3969/j.issn.2095-5707.2014.01.012]
 Li Zhe,Chang Nuan*,Li Li.The Policy History, Present Situation and Countermeasures of Chinese Medicine Hospital Preparations[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2014,38(6):38.[doi:10.3969/j.issn.2095-5707.2014.01.012]
[2]史磊,曹思思.基于利水功效组群药物的中药药性规律研究[J].中国中医药图书情报杂志,2014,38(4):10.[doi:10.3969/j.issn.2095-5707.2014.04.003]
 Shi Lei,Cao Sisi.A Study on Regularity of the Property of Chinese Materia Medica Based on Group Drugs with Diuretic Efficacy[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2014,38(6):10.[doi:10.3969/j.issn.2095-5707.2014.04.003]
[3]林敏华,吴昊,曾华敏,等.中药提取物及有效成分防治非酒精性脂肪性肝病的作用机制研究进展[J].中国中医药图书情报杂志,2020,44(1):72.[doi:10.3969/j.issn.2095-5707.2020.01.017]
 LIN Min-hua,WU Hao,ZENG Hua-min,et al.Research Progress in Mechanism of Action of Chinese Materia Medica Extracts and Active Components for Prevention and Treatment of Nonalcoholic Fatty Liver Disease[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(6):72.[doi:10.3969/j.issn.2095-5707.2020.01.017]
[4]黄凯文,刘芳.岭南医家江勒卿与《药物学注释》[J].中国中医药图书情报杂志,2020,44(4):48.[doi:10.3969/j.issn.2095-5707.2020.04.012]
 HUANG Kai-wen,LIU Fang.Lingnan Doctor Jiang Le-qing and Yao Wu Xue Zhu Shi[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2020,44(6):48.[doi:10.3969/j.issn.2095-5707.2020.04.012]
[5]郝雨培,崔妍彧,赵若楠,等.中药治疗子宫肌瘤的作用机制研究进展[J].中国中医药图书情报杂志,2021,45(4):69.[doi:10.3969/j.issn.2095-5707.2021.04.017]
 HAO Yu-pei,CUI Yan-yu,ZHAO Ruo-nan,et al.Research Progress in Mechanism of Chinese Materia Medica in the Treatment of Uterine Leiomyoma[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(6):69.[doi:10.3969/j.issn.2095-5707.2021.04.017]
[6]蒋志雄,朱智德*,祁祥,等.中药联合环磷腺苷葡胺治疗病毒性心肌炎的Meta分析[J].中国中医药图书情报杂志,2021,45(5):13.[doi:10.3969/j.issn.2095-5707.2021.05.003]
 JIANG Zhi-xiong,ZHU Zhi-de*,QI Xiang,et al.Meta-analysis on Chinese Materia Medica Combined with Meglumine Adenosine Cyclphosphate in the Treatment of Viral Myocarditis[J].Chinese Journal of Library and Information Science for Traditional Chinese Medicine,2021,45(6):13.[doi:10.3969/j.issn.2095-5707.2021.05.003]

备注/Memo

收稿日期:2021-05-16

基金项目:广州市哲学社会科学发展“十三五”规划2020年度共建课题(2020GZGJ135)
第一作者:支晓娟,E-mail: zhixiaojuan08@gzucm.edu.cn

更新日期/Last Update:

2021-11-04